Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis

Journal of Autoimmunity

Volumn 35, Issue 1, 2010, Pages 52-57

  Arora Singh, Rajpreet K ^a   Assassi, Shervin ^a   del Junco, Deborah J ^a   Arnett, Frank C ^a   Perry, Marilyn ^a   Irfan, Uzma ^a   Sharif, Roozbeh ^a   Mattar, Tony ^b   Mayes, Maureen D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Computer Task Force Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; DNA TOPOISOMERASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILIAL INCIDENCE; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; RELATIVE; RHEUMATOID ARTHRITIS; SPOUSE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; AGED; AUTOIMMUNE DISEASES; BLOOD; FAMILY; IMMUNOLOGY; MIDDLE AGED; PEDIGREE; RISK FACTOR; SCLERODERMA, SYSTEMIC;

AGED; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PREVALENCE; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 77953289232     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.02.001     Document Type: Article

References (40)

1. Arnett F.C., Cho M., Chatterjee S., Aguilar M.B., Reveille J.D., Mayes M.D. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001, 44:1359-1362.
2. Maddison P.J., Skinner R.P., Pereira R.S., Black C.M., Ansell B.M., Jayson M.I., et al. Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis 1986, 45:793-799.
3. Barnett A.J., McNeilage L.J. Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses. Ann Rheum Dis 1993, 52:365-368.
4. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., Lopez-Guzman S., Mantilla R.D., Chalem P., et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008, 31:156-159.
5. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330-337.
6. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004, 75:504-507.
7. Gourh P., Tan F.K., Assassi S., Ahn C.W., McNearney T.A., Fischbach M., et al. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum 2006, 54:3945-3953.
8. Onengut-Gumuscu S., Ewens K.G., Spielman R.S., Concannon P. A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families. Genes Immun 2004, 5:678-680.
9. Orozco G., Sanchez E., Gonzalez-Gay M.A., Lopez-Nevot M.A., Torres B., Caliz R., et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005, 52:219-224.
10. Criswell L.A., Pfeiffer K.A., Lum R.F., Gonzales B., Novitzke J., Kern M., et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005, 76:561-571.
11. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Lu Y., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555.
12. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
13. Rueda B., Broen J., Simeon C., Hesselstrand R., Diaz B., Suarez H., et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet 2009, 18:2071-2077.
14. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590.
15. Leroy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
16. Assassi S., Arnett F.C., Reveille J.D., Gourh P., Mayes M.D. Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum 2007, 56:2031-2037.
17. Broadley S.A., Deans J., Sawcer S.J., Clayton D., Compston D.A. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 2000, 123(Pt 6):1102-1111.
18. Steen V.D. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005, 35:35-42.
19. Arnett F.C. HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol 1995, 12:107-128.
20. Arnett FC, Gourh P, Shete S, Ahn CW, Honey R, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis doi:10.1136/ard.2009.111906.
21. Assassi S., Fritzler M.J., Arnett F.C., Norman G.L., Shah K.R., Gourh P., et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009, 36:2250-2256.
22. Ramos-Casals M., Nardi N., Brito-Zeron P., Aguilo S., Gil V., Delgado G., et al. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 2006, 35:312-321.
23. Szklo M., Nieto F.J. Measuring disease occurrence. Epidemiology beyond the basics 2007, Jone and Bartlett, Sudbury, p. 47-76.
24. Flores R.H., Stevens M.B., Arnett F.C. Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus. J Rheumatol 1984, 11:321-323.
25. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003, 100:2610-2615.
26. Tan F.K., Zhou X., Mayes M.D., Gourh P., Guo X., Marcum C., et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 2006, 45:694-702.
27. Dieude P., Guedj M., Wipff J., Avouac J., Fajardy I., Diot E., et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis. Arthritis Rheum 2009, 60:225-233.
28. Sigurdsson S., Nordmark G., Goring H.H., Lindroos K., Wiman A.C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005, 76:528-537.
29. Gourh P., Agarwal S.K., Martin E., Divecha D., Rueda B., Bunting H., et al. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun 2009 Sep 29, [Epub ahead of print].
30. Harley J.B., arcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40:204-210.
31. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358:900-909.
32. Mayes M.D. Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 1999, 5(107 Suppl):743-748.
33. Conrad K., Mehlhorn J., Luthke K., Dorner T., Frank K.H. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus 1996, 5:62-69.
34. Haustein U.F., Anderegg U. Silica induced scleroderma-clinical and experimental aspects. J Rheumatol 1998, 25:1917-1926.
35. Laing T.J., Gillespie B.W., Toth M.B., Mayes M.D., Gallavan R.H., Burns C.J., et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 2005, 40:734-742.
36. Silman A.J., Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?. Ann Rheum Dis 1992, 51:1322-1324.
37. Vanderpump M.P., Tunbridge W.M. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002, 12:839-847.
38. Roberts C.G., Ladenson P.W. Hypothyroidism. Lancet 2004, 363:793-803.
39. Cooper G.S., Wither J., McKenzie T., Claudio J.O., Bernatsky S., Fortin P.R. The prevalence and accuracy of self-reported history of 11 autoimmune diseases. J Rheumatol 2008, 35:2001-2004.
40. Wandstrat A.E., Carr-Johnson F., Branch V., Gray H., Fairhurst A.M., Reimold A., et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 2006, 27:153-160.